Evidence map›Paper›PMID 40700300›Full record

ArticleAntibodies (Basel, Switzerland)2025

Seroprevalence of IgG and IgE Antibodies Against

Eligia González-Rodríguez, Marta Rodero, J Alberto Montoya-Alonso, Kevin M Santana-Hernández, Myriam R Ventura, Carmen Cuéllar, Eligia Rodríguez-Ponce

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibodies (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eligia González-RodríguezDepartment of Animal Pathology and Production, Bromatology and Food Science and Technology, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.
Marta RoderoDepartment of Microbiology and Parasitology, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-6490-9297
J Alberto Montoya-AlonsoDepartment of Animal Pathology and Production, Bromatology and Food Science and Technology, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-2683-7592
Kevin M Santana-HernándezDepartment of Animal Pathology and Production, Bromatology and Food Science and Technology, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.
Myriam R VenturaDepartment of Animal Pathology and Production, Bromatology and Food Science and Technology, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0001-9037-2577
Carmen CuéllarDepartment of Microbiology and Parasitology, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-7948-9889
Eligia Rodríguez-PonceDepartment of Animal Pathology and Production, Bromatology and Food Science and Technology, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-9174-9708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food-borne zoonoses, particularly anisakiosis caused by

methodsThis study assessed

resultsOverall, 16.9% of samples were IgG-positive and 6.8% were IgE-positive. Seroprevalence was significantly higher in indi-viduals aged 60 years and above. Geographic heterogeneity was notable: La Palma had the highest IgG seroprevalence (35.3%), while El Hierro showed the highest IgE prevalence (16.3%). Temperate isoclimatic zones exhibited higher antibody prevalence than dry zones. These findings indicate variable

conclusionsThe results highlight the need for targeted public health interventions to reduce the anisakiosis risk, particularly in regions and populations with elevated exposure.

Indexed as

anisakiosisCanary IslandsELISAIgE antibodiesIgG antibodiesparasitic infectionseroprevalencezoonoses

Identifiers

PMID40700300
PMCPMC12286113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.